Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 17, 2022

SELL
$2.72 - $5.97 $40,587 - $89,084
-14,922 Closed
0 $0
Q4 2021

Feb 17, 2022

SELL
$5.17 - $8.65 $468,350 - $783,603
-90,590 Reduced 85.86%
14,922 $84,000
Q3 2021

Nov 12, 2021

BUY
$4.2 - $11.92 $363,610 - $1.03 Million
86,574 Added 457.14%
105,512 $779,000
Q2 2021

Sep 17, 2021

BUY
$4.93 - $6.69 $13,804 - $18,732
2,800 Added 17.35%
18,938 $100,000
Q1 2021

May 19, 2021

BUY
$4.3 - $7.48 $69,393 - $120,712
16,138 New
16,138 $87,000

About Edesa Biotech, Inc.


  • Ticker EDSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,462,300
  • Market Cap $27.2M
  • Description
  • Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...
More about EDSA
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.